Chairman, Regional Reference Multiple Sclerosis Centre
University Hospital San Luigi Gonzaga of Orbassano, Italy
Antonio Bertolotto, graduated in Medicine and specialized in Neurology at the University of Turin. He worked as Clinical Neurologist in the University of Turin till 1992, then he moved to the new Second Medical School of the University of Turin at S. Luigi Hospital, Orbassano (Turin), where he created the Multiple Sclerosis Clinic (CRESM = Centro Riferimento Regionale Sclerosi Multipla) that includes the Clinical Neurobiology Laboratory and the Experimental Neurophysiology Laboratory. Dr. Bertolotto is involved in both clinical activity and research in MS. The Clinical Neurobiology Laboratory serves as the Italy centre for the detection of antibodies neutralizing Interferon beta and Natalizumab. The research at the MS centre and Clinical Neurobiology Laboratory is focused on the identification of Disease Modifying Treatments non-responders, on evaluating the effects of pregnancy on gene-expression, on haematopoietic stem cell transplantation project and in several other clinical trials. Dr. Bertolotto is member of the scientific board of the Italian Association for MS and of the ”Therapeutics and Technology Assessment subcommittee of the American Academy of Neurology” for Interferon beta Neutralizing antibodies.
Clinical activity and research in Multiple Sclerosis.